In late 2013, Congress passed the Drug Quality and Security Act (DQSA) in response to a deadly fungal meningitis outbreak linked to a sterile compounded injectable drug shipped across the country and ...
The compounding pharmacy market, valued at approximately USD 15.1 billion in 2025, is forecast to reach nearly USD 20 billion by 2030, registering a compound annual growth rate (CAGR) of 5.7%, says ...
MONTREAL--(BUSINESS WIRE)--Medisca and EUROAPI have formed a strategic partnership focused on expanding API access for pharmaceutical compounding, creating differentiated access in North America and ...
Equity Commitment from Bain Capital Private Equity; Experienced Management Team from JHP Pharmaceuticals — August 24, 2015 – QuVa Pharma, Inc., a newly formed national platform for sterile compounding ...
BOULDER, Colo. — CordenPharma Colorado (CPC), an Active Pharmaceutical Ingredient (API) manufacturing facility in Boulder, Colorado, announces receipt of approval for the "Potent Compound Safety ...
The latest Health Policy Brief from Health Affairs and the Robert Wood Johnson Foundation examines the Compounding Quality Act, a law signed by President Obama in November 2013, which seeks to fill ...
Nanjing, China Compounding and LFT Expansion: the intended scope of this project adds approximately 52KT of compounding and long-fiber thermoplastics (LFT) capacity at the company’s Nanjing integrated ...
Based in Midland, Mich., MCC focuses on engineering resin compounding, advanced material development and closed-loop recycling technologies. MIDLAND — HydroGraph Clean Power Inc. announced on July 7 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results